Chlamydia pneumonia
Conditions
Interventions
Clinical performance test
Sponsors
Kawasaki Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with bronchitis or pulmonary inflammatory symptoms suspected of atypical pathogen infection
Exclusion criteria
Exclusion criteria: Use of prohibited drugs Macrolide tetracycline New quinolone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistency of results of PCR method and test of antibody titer method and LAMP method | — |
Countries
Japan
Contacts
Public ContactHiroto Akaike
Kawasaki Medical School pediatrics
Outcome results
None listed